{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T03:54:00Z","timestamp":1776657240639,"version":"3.51.2"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.imlet.2023.06.004","type":"journal-article","created":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T13:54:35Z","timestamp":1686146075000},"page":"11-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Comparison of effects of multiple adjuvants and immunization routes on the immunogenicity and protection of HSV-2 gD subunit vaccine"],"prefix":"10.1016","volume":"260","author":[{"given":"Mingming","family":"Wan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiheng","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linjun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunlai","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8221-2215","authenticated-orcid":false,"given":"Yan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2023.06.004_bib0001","unstructured":"WHO, https:\/\/www.who.int\/news\/item\/01-05-2020-billions-worldwide-living-with-herpes. 2020."},{"issue":"12","key":"10.1016\/j.imlet.2023.06.004_bib0002","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1128\/jvi.61.12.3726-3732.1987","article-title":"Activation of the human immunodeficiency virus by herpes simplex virus type 1","volume":"61","author":"Ostrove","year":"1987","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.imlet.2023.06.004_bib0003","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00126334-200404150-00001","article-title":"The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics","volume":"35","author":"Corey","year":"2004","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"8","key":"10.1016\/j.imlet.2023.06.004_bib0004","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/nm.2006","article-title":"Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition","volume":"15","author":"Zhu","year":"2009","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.imlet.2023.06.004_bib0005","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1128\/JVI.03047-12","article-title":"CD4 T-cell memory responses to viral infections of humans show pronounced immunodominance independent of duration or viral persistence","volume":"87","author":"Jing","year":"2013","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.imlet.2023.06.004_bib0006","doi-asserted-by":"crossref","first-page":"e34635","DOI":"10.1371\/journal.pone.0034635","article-title":"Infant safety during and after maternal valacyclovir therapy in conjunction with antiretroviral HIV-1 prophylaxis in a randomized clinical trial","volume":"7","author":"Drake","year":"2012","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.imlet.2023.06.004_bib0007","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1128\/jvi.49.1.102-108.1984","article-title":"Localization and synthesis of an antigenic determinant of herpes simplex virus glycoprotein D that stimulates the production of neutralizing antibody","volume":"49","author":"Cohen","year":"1984","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.imlet.2023.06.004_bib0008","doi-asserted-by":"crossref","first-page":"6604","DOI":"10.4049\/jimmunol.181.9.6604","article-title":"Immunodominant epitopes in herpes simplex virus type 2 glycoprotein D are recognized by CD4 lymphocytes from both HSV-1 and HSV-2 seropositive subjects","volume":"181","author":"Kim","year":"2008","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2023.06.004_bib0009","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1086\/315208","article-title":"Limited antibody-dependent cellular cytotoxicity antibody response induced by a herpes simplex virus type 2 subunit vaccine","volume":"181","author":"Kohl","year":"2000","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.imlet.2023.06.004_bib0010","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa1103151","article-title":"Efficacy results of a trial of a herpes simplex vaccine","volume":"366","author":"Belshe","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imlet.2023.06.004_bib0011","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.trsl.2020.03.004","article-title":"Vaccines to prevent genital herpes","volume":"220","author":"Egan","year":"2020","journal-title":"Transl Res"},{"issue":"4","key":"10.1016\/j.imlet.2023.06.004_bib0012","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","article-title":"Vaccine adjuvants: putting innate immunity to work","volume":"33","author":"Coffman","year":"2010","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.imlet.2023.06.004_bib0013","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1093\/infdis\/174.6.1168","article-title":"MF59 adjuvant enhances the antibody response to recombinant hepatitis B surface antigen vaccine in primates","volume":"174","author":"Traquina","year":"1996","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.imlet.2023.06.004_bib0014","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11908-003-0048-0","article-title":"Glycoprotein d-adjuvant vaccine to prevent genital herpes","volume":"5","author":"Erbelding","year":"2003","journal-title":"Curr. Infect. Dis. Rep."},{"issue":"38","key":"10.1016\/j.imlet.2023.06.004_bib0015","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1016\/j.vaccine.2019.07.098","article-title":"Adjuvant Systems for vaccines: 13years of post-licensure experience in diverse populations have progressed the way adjuvanted vaccine safety is investigated and understood","volume":"37","author":"Laupeze","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2023.06.004_bib0016","doi-asserted-by":"crossref","first-page":"13324","DOI":"10.1038\/ncomms13324","article-title":"Saponin-based adjuvants induce cross-presentation in dendritic cells by intracellular lipid body formation","volume":"7","author":"den Brok","year":"2016","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.imlet.2023.06.004_bib0017","doi-asserted-by":"crossref","first-page":"5283","DOI":"10.1128\/JVI.02013-05","article-title":"Mucosal administration of CpG oligodeoxynucleotide elicits strong CC and CXC chemokine responses in the vagina and serves as a potent Th1-tilting adjuvant for recombinant gD2 protein vaccination against genital herpes","volume":"80","author":"Tengvall","year":"2006","journal-title":"J. Virol."},{"issue":"16","key":"10.1016\/j.imlet.2023.06.004_bib0018","doi-asserted-by":"crossref","first-page":"8948","DOI":"10.1128\/JVI.77.16.8948-8956.2003","article-title":"Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2","volume":"77","author":"Ashkar","year":"2003","journal-title":"J. Virol."},{"issue":"29","key":"10.1016\/j.imlet.2023.06.004_bib0019","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1016\/j.vaccine.2012.02.019","article-title":"Nasal and skin delivery of IC31((R))-adjuvanted recombinant HSV-2 gD protein confers protection against genital herpes","volume":"30","author":"Wizel","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2023.06.004_bib0020","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1016\/j.vaccine.2004.01.059","article-title":"Intravaginal immunization with viral subunit protein plus CpG oligodeoxynucleotides induces protective immunity against HSV-2","volume":"22","author":"Kwant","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2023.06.004_bib0021","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3389\/fimmu.2013.00282","article-title":"Bacterium-like particles for efficient immune stimulation of existing vaccines and new subunit vaccines in mucosal applications","volume":"4","author":"Van Braeckel-Budimir","year":"2013","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2023.06.004_bib0022","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/mi.2009.131","article-title":"Neonatal mucosal immunization with a non-living, non-genetically modified Lactococcus lactis vaccine carrier induces systemic and local Th1-type immunity and protects against lethal bacterial infection","volume":"3","author":"Ramirez","year":"2010","journal-title":"Mucosal Immunol."},{"issue":"26","key":"10.1016\/j.imlet.2023.06.004_bib0023","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.1016\/j.vaccine.2006.03.054","article-title":"Lactococcus lactis GEM particles displaying pneumococcal antigens induce local and systemic immune responses following intranasal immunization","volume":"24","author":"Audouy","year":"2006","journal-title":"Vaccine"},{"issue":"18","key":"10.1016\/j.imlet.2023.06.004_bib0024","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1016\/j.vaccine.2006.02.040","article-title":"Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral immunisations","volume":"24","author":"Ramasamy","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2023.06.004_bib0025","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1475-2875-11-50","article-title":"Bacterium-like particles as multi-epitope delivery platform for Plasmodium berghei circumsporozoite protein induce complete protection against malaria in mice","volume":"11","author":"Nganou-Makamdop","year":"2012","journal-title":"Malar J."},{"issue":"2","key":"10.1016\/j.imlet.2023.06.004_bib0026","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1208\/s12248-009-9168-2","article-title":"Intranasal delivery of influenza subunit vaccine formulated with GEM particles as an adjuvant","volume":"12","author":"Saluja","year":"2010","journal-title":"AAPS J."},{"issue":"32","key":"10.1016\/j.imlet.2023.06.004_bib0027","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.1016\/j.vaccine.2012.04.032","article-title":"Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration","volume":"30","author":"de Haan","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.imlet.2023.06.004_bib0028","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ymeth.2005.09.015","article-title":"Mucosal vaccine delivery of antigens tightly bound to an adjuvant particle made from food-grade bacteria","volume":"38","author":"van Roosmalen","year":"2006","journal-title":"Methods"},{"issue":"5","key":"10.1016\/j.imlet.2023.06.004_bib0029","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/1348-0421.12482","article-title":"Evaluation of recombinant adenovirus vaccines based on glycoprotein D and truncated UL25 against herpes simplex virus type 2 in mice","volume":"61","author":"Liu","year":"2017","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.imlet.2023.06.004_bib0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.imlet.2020.03.002","article-title":"An HIV-1 vaccine based on bacterium-like particles elicits Env-specific mucosal immune responses","volume":"222","author":"Bi","year":"2020","journal-title":"Immunol. Lett."},{"issue":"3","key":"10.1016\/j.imlet.2023.06.004_bib0031","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/infdis\/146.3.397","article-title":"Genital herpes in guinea pigs: pathogenesis of the primary infection and description of recurrent disease","volume":"146","author":"Stanberry","year":"1982","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.imlet.2023.06.004_bib0032","article-title":"Combination of innate immune modulators as vaccine adjuvants in mice","volume":"8","author":"Haddadi","year":"2020","journal-title":"Vaccines (Basel),"},{"issue":"2","key":"10.1016\/j.imlet.2023.06.004_bib0033","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.vaccine.2004.05.011","article-title":"Interleukin-12 redirects murine immune responses to soluble or aluminum phosphate adsorbed HSV-2 glycoprotein D towards Th1 and CD4+ CTL responses","volume":"23","author":"Cooper","year":"2005","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.imlet.2023.06.004_bib0034","doi-asserted-by":"crossref","first-page":"e17748","DOI":"10.1371\/journal.pone.0017748","article-title":"A live-attenuated HSV-2 ICP0 virus elicits 10 to 100 times greater protection against genital herpes than a glycoprotein D subunit vaccine","volume":"6","author":"Halford","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.imlet.2023.06.004_bib0035","first-page":"7","article-title":"Immunogenicity and efficacy of intramuscular replication-defective and subunit vaccines against herpes simplex virus type 2 in the mouse genital model","author":"Delagrave","year":"2012","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.imlet.2023.06.004_bib0036","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1089\/vim.2016.0136","article-title":"An interleukin 12 adjuvanted herpes simplex virus 2 DNA vaccine is more protective than a glycoprotein D subunit vaccine in a high-dose murine challenge model","volume":"30","author":"Bagley","year":"2017","journal-title":"Viral Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2023.06.004_bib0037","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.vaccine.2015.10.137","article-title":"A novel HSV-2 subunit vaccine induces GLA-dependent CD4 and CD8 T cell responses and protective immunity in mice and guinea pigs","volume":"34","author":"Odegard","year":"2016","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.imlet.2023.06.004_bib0038","article-title":"Virologic and immunologic evidence of multifocal genital herpes simplex virus 2 infection","volume":"88","author":"C","year":"2014","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.imlet.2023.06.004_bib0039","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1099\/0022-1317-83-11-2797","article-title":"Modification of primary and recurrent genital herpes in guinea pigs by passive immunization","volume":"83","author":"Bourne","year":"2002","journal-title":"J. General Virol."},{"issue":"9","key":"10.1016\/j.imlet.2023.06.004_bib0040","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1084\/jem.191.9.1459","article-title":"Cd8+ T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons","volume":"191","author":"Liu","year":"2000","journal-title":"J. Experimental Med."},{"key":"10.1016\/j.imlet.2023.06.004_bib0041","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1099\/0022-1317-61-1-127","article-title":"Pathogenesis of herpes simplex virus in B cell-suppressed mice: the relative roles of cell-mediated and humoral immunity","volume":"61","author":"Kapoor","year":"1982","journal-title":"J. General Virol."},{"issue":"1","key":"10.1016\/j.imlet.2023.06.004_bib0042","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jri.2011.01.013","article-title":"Rapid clearance of herpes simplex virus type 2 by CD8+ T cells requires high level expression of effector T cell functions","volume":"89","author":"Nelson","year":"2011","journal-title":"J. Reprod. Immunol."},{"issue":"23","key":"10.1016\/j.imlet.2023.06.004_bib0043","doi-asserted-by":"crossref","first-page":"14546","DOI":"10.1128\/JVI.79.23.14546-14554.2005","article-title":"Clearance of herpes simplex virus type 2 by CD8+ T cells requires gamma interferon and either perforin- or Fas-mediated Cytolytic mechanisms","volume":"79","author":"Dobbs","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.imlet.2023.06.004_bib0044","unstructured":"Long, D., et\u00a0al., identification of novel virus-specific antigens by cd4 and cd8 t cells from asymptomatic hsv-2 seropositive and seronegative donors. 2019."},{"issue":"52","key":"10.1016\/j.imlet.2023.06.004_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2012.10.046","article-title":"The efficacy of HSV-2 vaccines based on gD and gB is enhanced by the addition of ICP27","volume":"30","author":"Bright","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2023.06.004_bib0046","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.smim.2018.05.001","article-title":"Correlates of adjuvanticity: a review on adjuvants in licensed vaccines","volume":"39","author":"Del Giudice","year":"2018","journal-title":"Semin. Immunol."},{"issue":"5","key":"10.1016\/j.imlet.2023.06.004_bib0047","first-page":"779","article-title":"Novel adjuvants & delivery vehicles for vaccines development: a road ahead","volume":"138","author":"Mohan","year":"2013","journal-title":"Indian J. Med. Res."},{"issue":"4","key":"10.1016\/j.imlet.2023.06.004_bib0048","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.3233\/JAD-200351","article-title":"Stimulation effects and mechanisms of different adjuvants on a norovirus P particle-based active amyloid-\u03b2 vaccine","volume":"77","author":"Dai","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.imlet.2023.06.004_bib0049","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.526965","article-title":"Respiratory Syncytial virus F subunit vaccine with AS02 adjuvant elicits balanced, robust humoral and cellular immunity in BALB\/c mice","volume":"11","author":"Zheng","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2023.06.004_bib0050","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00430-019-00579-9","article-title":"Comparison of four adjuvants revealed the strongest protection against lethal pneumococcal challenge following immunization with PsaA-PspA fusion protein and AS02 as adjuvant","volume":"208","author":"Chen","year":"2019","journal-title":"Med. Microbiol. Immunol."},{"issue":"9","key":"10.1016\/j.imlet.2023.06.004_bib0051","doi-asserted-by":"crossref","DOI":"10.3390\/v11090799","article-title":"A novel bacterium-like particle vaccine displaying the MERS-CoV receptor-binding domain induces specific mucosal and systemic immune responses in mice","volume":"11","author":"Li","year":"2019","journal-title":"Viruses"},{"issue":"8","key":"10.1016\/j.imlet.2023.06.004_bib0052","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1586\/erv.09.60","article-title":"New concepts in herpes simplex virus vaccine development: notes from the battlefield","volume":"8","author":"Dasgupta","year":"2009","journal-title":"Expert Rev. Vaccines"},{"issue":"9","key":"10.1016\/j.imlet.2023.06.004_bib0053","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002252","article-title":"Robust antigen specific th17 T cell response to group A Streptococcus is dependent on IL-6 and intranasal route of infection","volume":"7","author":"Dileepan","year":"2011","journal-title":"PLoS Pathog."},{"issue":"4","key":"10.1016\/j.imlet.2023.06.004_bib0054","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2013730118","article-title":"Mycobacterium tuberculosisSynthetic protein conjugate vaccines provide protection against in mice","volume":"118","author":"Hanna","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.imlet.2023.06.004_bib0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1082273","article-title":"The adjuvant effect of bacterium-like particles depends on the route of administration","volume":"14","author":"Sudo","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2023.06.004_bib0056","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3389\/fimmu.2020.00348","article-title":"Transcriptional regulators of T Helper 17 cell differentiation in health and autoimmune diseases","volume":"11","author":"Capone","year":"2020","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.imlet.2023.06.004_bib0057","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens11121547","article-title":"The double game played by Th17 cells in infection: host defense and immunopathology","volume":"11","author":"Paroli","year":"2022","journal-title":"Pathogens"},{"issue":"5","key":"10.1016\/j.imlet.2023.06.004_bib0058","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005589","article-title":"Estradiol enhances CD4+ T-cell anti-viral immunity by priming vaginal DCs to induce Th17 responses via an IL-1-dependent pathway","volume":"12","author":"Anipindi","year":"2016","journal-title":"PLoS Pathog."},{"issue":"23","key":"10.1016\/j.imlet.2023.06.004_bib0059","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01234-17","article-title":"Novel role for interleukin-17 in enhancing type 1 Helper T cell immunity in the female genital tract following mucosal herpes simplex virus 2 vaccination","volume":"91","author":"Bagri","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.imlet.2023.06.004_bib0060","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.849515","article-title":"Combinatorial herpes simplex vaccine strategies: from bedside to bench and back","volume":"13","author":"Chentoufi","year":"2022","journal-title":"Front. Immunol."},{"issue":"14","key":"10.1016\/j.imlet.2023.06.004_bib0061","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.vaccine.2014.01.052","article-title":"Summary and recommendations from a national institute of allergy and infectious diseases (NIAID) workshop on \"Next generation herpes simplex virus vaccines\"","volume":"32","author":"Knipe","year":"2014","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.imlet.2023.06.004_bib0062","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1056\/NEJMoa011915","article-title":"Glycoprotein-d-adjuvant vaccine to prevent genital herpes","volume":"347","author":"Stanberry","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"51","key":"10.1016\/j.imlet.2023.06.004_bib0063","doi-asserted-by":"crossref","first-page":"6136","DOI":"10.1016\/j.vaccine.2013.06.081","article-title":"Safety and immunogenicity of a glycoprotein D genital herpes vaccine in healthy girls 10-17 years of age: results from a randomised, controlled, double-blind trial","volume":"31","author":"Abu-Elyazeed","year":"2013","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.imlet.2023.06.004_bib0064","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/SHK.0000000000001623","article-title":"Aluminum adjuvant improves survival via NLRP3 Inflammasome and myeloid non-granulocytic cells in a murine model of neonatal sepsis","volume":"55","author":"Rincon","year":"2021","journal-title":"Shock"},{"issue":"47","key":"10.1016\/j.imlet.2023.06.004_bib0065","doi-asserted-by":"crossref","first-page":"7483","DOI":"10.1016\/j.vaccine.2010.09.014","article-title":"DNA vaccine delivery by densely-packed and short microprojection arrays to skin protects against vaginal HSV-2 challenge","volume":"28","author":"Kask","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2023.06.004_bib0066","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/1743-422X-10-317","article-title":"Single dose of glycoprotein K (gK)-deleted HSV-1 live-attenuated virus protects mice against lethal vaginal challenge with HSV-1 and HSV-2 and induces lasting T cell memory immune responses","volume":"10","author":"Iyer","year":"2013","journal-title":"Virol. J."},{"issue":"43","key":"10.1016\/j.imlet.2023.06.004_bib0067","doi-asserted-by":"crossref","first-page":"6470","DOI":"10.1016\/j.vaccine.2019.08.077","article-title":"Intranasal nanoemulsion-adjuvanted HSV-2 subunit vaccine is effective as a prophylactic and therapeutic vaccine using the guinea pig model of genital herpes","volume":"37","author":"Bernstein","year":"2019","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.imlet.2023.06.004_bib0068","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101373","article-title":"A herpes simplex virus 2 (HSV-2) glycoprotein d-expressing nonreplicating dominant-negative HSV-2 virus vaccine is superior to a gD2 subunit vaccine against HSV-2 genital infection in guinea pigs","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.imlet.2023.06.004_bib0069","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3390\/v15010219","article-title":"An adenovirus-based recombinant herpes simplex virus 2 (HSV-2) therapeutic vaccine is highly protective against acute and recurrent HSV-2 disease in a guinea pig model","volume":"15","author":"Wan","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.imlet.2023.06.004_bib0070","doi-asserted-by":"crossref","DOI":"10.1007\/s12250-020-00330-2","article-title":"Herpesviruses and the Type III interferon system","author":"Yin","year":"2021","journal-title":"Virol. Sin."},{"key":"10.1016\/j.imlet.2023.06.004_bib0071","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1007\/s10875-007-9163-2","article-title":"Autoimmunity in IgA deficiency: revisiting the role of IgA as a silent housekeeper","author":"Jacob","year":"2008","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.imlet.2023.06.004_bib0072","article-title":"Innate mechanisms in selective IgA deficiency","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2023.06.004_bib0073","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1749-6632.2011.06266.x","article-title":"Regulation of mucosal IgA responses: lessons from primary immunodeficiencies","volume":"1238","author":"Cerutti","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1\u20133","key":"10.1016\/j.imlet.2023.06.004_bib0074","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s12026-012-8318-2","article-title":"Human B cell defects in perspective","volume":"54","author":"Cunningham-Rundles","year":"2012","journal-title":"Immunol. Res."},{"issue":"12","key":"10.1016\/j.imlet.2023.06.004_bib0075","doi-asserted-by":"crossref","DOI":"10.3390\/v11121149","article-title":"A novel bacterium-like particle-based vaccine displaying the SUDV glycoprotein induces potent humoral and cellular immune responses in mice","volume":"11","author":"Xu","year":"2019","journal-title":"Viruses"},{"issue":"7","key":"10.1016\/j.imlet.2023.06.004_bib0076","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1111\/1751-7915.14022","article-title":"Vaccine with bacterium-like particles displaying HIV-1 gp120 trimer elicits specific mucosal responses and neutralizing antibodies in rhesus macaques","volume":"15","author":"Wang","year":"2022","journal-title":"Microb. Biotechnol."},{"issue":"8","key":"10.1016\/j.imlet.2023.06.004_bib0077","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.4161\/hv.29375","article-title":"Evaluation of the immune response to RTS,S\/AS01 and RTS,S\/AS02 adjuvanted vaccines: randomized, double-blind study in malaria-na\u00efve adults","volume":"10","author":"Leroux-Roels","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"issue":"29","key":"10.1016\/j.imlet.2023.06.004_bib0078","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1016\/j.vaccine.2014.03.040","article-title":"Effects of varying antigens and adjuvant systems on the immunogenicity and safety of investigational tetravalent human oncogenic papillomavirus vaccines: results from two randomized trials","volume":"32","author":"Van Damme","year":"2014","journal-title":"Vaccine"},{"issue":"23","key":"10.1016\/j.imlet.2023.06.004_bib0079","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1016\/j.vaccine.2016.04.019","article-title":"Strain-specific plasmodium falciparum multifunctional CD4(+) T cell cytokine expression in Malian children immunized with the FMP2.1\/AS02A vaccine candidate","volume":"34","author":"Graves","year":"2016","journal-title":"Vaccine"},{"issue":"29","key":"10.1016\/j.imlet.2023.06.004_bib0080","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1016\/j.vaccine.2018.06.004","article-title":"A systematic review and meta-analysis on the safety of newly adjuvanted vaccines among older adults","volume":"36","author":"Baay","year":"2018","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.imlet.2023.06.004_bib0081","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.vaccine.2015.12.024","article-title":"A systematic review and meta-analysis on the safety of newly adjuvanted vaccines among children","volume":"34","author":"Stassijns","year":"2016","journal-title":"Vaccine"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247823000974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247823000974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:41:47Z","timestamp":1759045307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247823000974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":81,"alternative-id":["S0165247823000974"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2023.06.004","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of effects of multiple adjuvants and immunization routes on the immunogenicity and protection of HSV-2 gD subunit vaccine","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2023.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V. on behalf of European Federation of Immunological Societies.","name":"copyright","label":"Copyright"}]}}